Your browser doesn't support javascript.
loading
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.
Cele, Sandile; Gazy, Inbal; Jackson, Laurelle; Hwa, Shi-Hsia; Tegally, Houriiyah; Lustig, Gila; Giandhari, Jennifer; Pillay, Sureshnee; Wilkinson, Eduan; Naidoo, Yeshnee; Karim, Farina; Ganga, Yashica; Khan, Khadija; Bernstein, Mallory; Balazs, Alejandro B; Gosnell, Bernadett I; Hanekom, Willem; Moosa, Mahomed-Yunus S; Lessells, Richard J; de Oliveira, Tulio; Sigal, Alex.
Afiliación
  • Cele S; Africa Health Research Institute, Durban, South Africa.
  • Gazy I; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Jackson L; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Hwa SH; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Tegally H; Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Hadassah Medical School, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Lustig G; Africa Health Research Institute, Durban, South Africa.
  • Giandhari J; Africa Health Research Institute, Durban, South Africa.
  • Pillay S; Division of Infection and Immunity, University College London, London, UK.
  • Wilkinson E; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Naidoo Y; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
  • Karim F; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Ganga Y; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Khan K; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Bernstein M; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Balazs AB; Africa Health Research Institute, Durban, South Africa.
  • Gosnell BI; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Hanekom W; Africa Health Research Institute, Durban, South Africa.
  • Moosa MS; Africa Health Research Institute, Durban, South Africa.
  • Lessells RJ; Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • de Oliveira T; Africa Health Research Institute, Durban, South Africa.
  • Sigal A; Division of Infection and Immunity, University College London, London, UK.
Nature ; 593(7857): 142-146, 2021 05.
Article en En | MEDLINE | ID: mdl-33780970
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Evasión Inmune / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales / Mutación Límite: Animals / Humans País/Región como asunto: Africa Idioma: En Revista: Nature Año: 2021 Tipo del documento: Article País de afiliación: Sudáfrica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Evasión Inmune / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales / Mutación Límite: Animals / Humans País/Región como asunto: Africa Idioma: En Revista: Nature Año: 2021 Tipo del documento: Article País de afiliación: Sudáfrica